FEMS Webinar on Vaccines in the Time of COVID-19

Join us for a webinar on the vitally important subject of vaccines in the time of COVID-19. Enjoy three insightful talks on vaccine development, followed by an in depth Q&A and discussion where you can put your questions on vaccines to our esteemed speakers. This is one not to miss!

Register via this link

Wednesday 10th March, 2021

10 am EST / 3pm GMT / 16:00 CET / 23:00 CST 

This webinar will feature:

Chair: Dr Alfredo Garzino-Demo, Editor-in-Chief of Pathogens and Disease. Associate Professor at the Institute of Human Virology, and the Department of Microbiology and Immunology of the University of Maryland School of Medicine (USA); and at the University of Padova (Italy)




Speaker 1: Dr Kizzmekia Corbett, National Institutes of Health, USA

Dr Kizzmekia Corbett is a research fellow and the scientific lead for the Coronavirus Vaccines and Immunopathogenesis Team at  the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases, Vaccine Research Center (VRC). A viral immunologist by training, Dr Corbett uses her expertise to propel novel vaccine development for pandemic preparedness. In response to the ongoing global COVID-19 pandemic, the vaccine concept incorporated in mRNA-1273 was designed by Dr Corbett’s team from viral sequence data and rapidly deployed to industry partner Moderna.


Speaker 2: Dr Florian Krammer, Icahn School of Medicine at Mount Sinai, USA

Talk title: Antibody responses to SARS-CoV-2 spike

Dr Florian Krammer is a Professor of Vaccinology at the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and since 2019 has been the Principal Investigator of the Sinai-Emory Multi-Institutional Collaborative Influenza Vaccine Innovation Center (SEM-CIVIC). The Krammer laboratory, also part of the NIH-funded Centers for Excellence in Influenza Research and Surveillance, focuses on understanding broadly-reactive immune responses against the surface glycoproteins of RNA viruses such as influenza with the goal to develop better vaccines and novel therapeutics.


Speaker 3: Dr Rino Rappuoli, GSK Vaccines, Italy

Dr Rino Rappuoli is Chief Scientist and Head External R&D at GSK Vaccines, and Professor of Vaccines Research at Imperial College, London, UK. Dr Rappuoli has introduced several novel scientific concepts over the course of his career; examples include genetic detoxification, cellular microbiology, reverse vaccinology, and observation of the pangenome. He has been instrumental to the development of many vaccines, including those against H. influenzae, N. meningitidis, pneumococcus, pertussis, and meningitis.

He is an author on the recent microLife paper Development of vaccines at the time of COVID-19.


microLife – The journal of the FEMS European Academy of Microbiology

As the journal of the European Academy of Microbiology (EAM)microLife is the platform for leading experts in microbiology, publishing outstanding papers of the highest standard, novelty, and significance. All microbes are covered, including bacteria, archaea, fungi, protists, parasites, and viruses. The journal is fully gold open access and all articles are free to read.


This event is free to access for all and is part of a series of webinars by FEMS with Oxford University Press.

Registration link
Share this opportunity